OPKO Health (NASDAQ:OPK) was one of the many diagnostic testing companies that saw volumes increase dramatically in 2020, with revenue up 49% through the first nine months of 2020. Below are three things to expect from the company in 2021.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,